Clinical Trials Directory

Trials / Completed

CompletedNCT05671237

The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block for Rhinoplasty Operations

The Effect of Bilateral Infraorbital+ Infratrochlear Nerve Block on Perioperative Remifentanil Consumption and Postoperative Pain Scores for Rhinoplasty Operations

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Istanbul University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of our study is to examine the effect of bilateral infraorbital and infratrochlear nerve blocks for rhinoplasty operations on perioperative remifentanil need and postoperative pain scores.

Detailed description

Rhinoplasty operations are one of the most applied cosmetic surgeries in the world. Depending on the procedure type and hemodynamic lability, the quality of the surgical field, perioperative and postoperative complications as well as the success of surgery are affected.To provide improved surgical field quality, controlled hypotension and high concentrations of inhalation anesthetics, magnesium sulfate, remifentanil, clonidine, calcium channel blockers, tranexamic acid, intravenous nitroglycerin have been used. The American Society of Anesthesiology recommends using regional anesthesia methods and administering multimodal analgesia in every possible surgery. In our study we have performed bilaterral infraorbital an infratrochlear nerve blocks which are main nerves of the nose, for the patients of rhinoplasty. With blocking the infratrochlear and infraorbital nerves we will examine the need for remifentanil during surgery, postoperative pain scores.

Conditions

Interventions

TypeNameDescription
OTHERbilateral infraorbital+infratrochlear blockwe will perform bilateral infraorbital+infratrochlear nerve block

Timeline

Start date
2022-11-11
Primary completion
2023-02-15
Completion
2023-03-01
First posted
2023-01-04
Last updated
2023-06-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05671237. Inclusion in this directory is not an endorsement.